Product Information
VOQUEZNA 20 MG TABLET is a brand product labeled by Phathom Pharmaceuticals Inc., priced at $22.4121 per EA under NDC 81520020030. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Nov 1, 2023.
Strength
26.72 mg/1
Manufacturer
Phathom Pharmaceuticals Inc.NDC
81520020030
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
VONOPRAZAN FUMARATEApproval Type
New Drug (NDA)
FDA Application
NDA215151FDA Approved
11/1/2023
On Market Since
11/10/2023
Price Statistics
The NADAC for VOQUEZNA 20 MG TABLET has been published 129 times since Apr 17, 2024, and over the history we have for it it has risen 8.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $22.4121 per EA |
|---|---|
| All-time high | $22.4351 (Jul 15, 2026) |
| All-time low | $20.7081 (Apr 17, 2024) |
| 52-week high | $22.4351 |
| 52-week low | $21.7647 |
| Median price | $21.7750 |
| Average price | $21.6818 |
| Largest weekly change | +5.0% (Jan 8, 2025) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the vonoprazan fumarate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Phathom Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
vonoprazan fumarate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VOQUEZNA 20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VOQUEZNA 20 MG TABLET, manufactured by Phathom Pharmaceuticals Inc., is $22.4121 per EA (NDC 81520020030), effective Sep 30, 2026.
How has the price of VOQUEZNA 20 MG TABLET changed over time?
Over the history we have for it, the NADAC for VOQUEZNA 20 MG TABLET has risen 8.2%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for VOQUEZNA 20 MG TABLET?
Since Apr 17, 2024, the NADAC for VOQUEZNA 20 MG TABLET has ranged from a low of $20.7081 (Apr 17, 2024) to a high of $22.4351 (Jul 15, 2026), with a median of $21.7750 per EA.
Are there cheaper alternatives to VOQUEZNA 20 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of VOQUEZNA 20 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures VOQUEZNA 20 MG TABLET?
VOQUEZNA 20 MG TABLET (NDC 81520020030) is labeled by Phathom Pharmaceuticals Inc., and CMS classifies it as a brand product.